These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34353938)

  • 1. Maturation of HIV-1.
    Hikichi Y; Freed EO
    Science; 2021 Aug; 373(6555):621-622. PubMed ID: 34353938
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV-1 assembly, release and maturation.
    Freed EO
    Nat Rev Microbiol; 2015 Aug; 13(8):484-96. PubMed ID: 26119571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic and mass spectrometry-based investigation of human immunodeficiency virus type 1 assembly and maturation.
    Lanman J; Prevelige PE
    Adv Virus Res; 2005; 64():285-309. PubMed ID: 16139598
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of a Structural Element in HIV-1 Gag Required for Virus Particle Assembly and Maturation.
    Novikova M; Adams LJ; Fontana J; Gres AT; Balasubramaniam M; Winkler DC; Kudchodkar SB; Soheilian F; Sarafianos SG; Steven AC; Freed EO
    mBio; 2018 Oct; 9(5):. PubMed ID: 30327442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus type 1 resistance to the small molecule maturation inhibitor 3-O-(3',3'-dimethylsuccinyl)-betulinic acid is conferred by a variety of single amino acid substitutions at the CA-SP1 cleavage site in Gag.
    Zhou J; Chen CH; Aiken C
    J Virol; 2006 Dec; 80(24):12095-101. PubMed ID: 17035324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 Maturation: Lessons Learned from Inhibitors.
    Kleinpeter AB; Freed EO
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32858867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 Mutant Assembly, Processing and Infectivity Expresses Pol Independent of Gag.
    Yu FH; Huang KJ; Wang CT
    Viruses; 2020 Jan; 12(1):. PubMed ID: 31906562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assembly and maturation of HIV-1--targets for new anti-HIV compounds].
    Bukrinskaia AG; Vorkunova GK; Burshteĭn ME
    Mol Gen Mikrobiol Virusol; 2005; (1):18-23. PubMed ID: 15790028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insight into the mechanism of action of EP-39, a bevirimat derivative that inhibits HIV-1 maturation.
    Neyret A; Gay B; Cransac A; Briant L; Coric P; Turcaud S; Laugâa P; Bouaziz S; Chazal N
    Antiviral Res; 2019 Apr; 164():162-175. PubMed ID: 30825471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of ribosomal frameshifting for human immunodeficiency virus type 1 particle assembly and replication.
    Hung M; Patel P; Davis S; Green SR
    J Virol; 1998 Jun; 72(6):4819-24. PubMed ID: 9573247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of structural protein Gag and related gene (protein) in late stages of the HIV-1 replication cycle and the inhibitors].
    Jiang Y; Liu XY
    Yao Xue Xue Bao; 2010 Feb; 45(2):205-14. PubMed ID: 21351430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical Reconstitution of HIV-1 Assembly and Maturation.
    Kucharska I; Ding P; Zadrozny KK; Dick RA; Summers MF; Ganser-Pornillos BK; Pornillos O
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31801870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of an HIV-1 maturation inhibitor on the structure and dynamics of CA-SP1 junction helices in virus-like particles.
    Gupta S; Louis JM; Tycko R
    Proc Natl Acad Sci U S A; 2020 May; 117(19):10286-10293. PubMed ID: 32341150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of HIV-1 Maturation via Small-Molecule Targeting of the Amino-Terminal Domain in the Viral Capsid Protein.
    Wang W; Zhou J; Halambage UD; Jurado KA; Jamin AV; Wang Y; Engelman AN; Aiken C
    J Virol; 2017 May; 91(9):. PubMed ID: 28202766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple Roles of HIV-1 Capsid during the Virus Replication Cycle.
    Novikova M; Zhang Y; Freed EO; Peng K
    Virol Sin; 2019 Apr; 34(2):119-134. PubMed ID: 31028522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro resistance to the human immunodeficiency virus type 1 maturation inhibitor PA-457 (Bevirimat).
    Adamson CS; Ablan SD; Boeras I; Goila-Gaur R; Soheilian F; Nagashima K; Li F; Salzwedel K; Sakalian M; Wild CT; Freed EO
    J Virol; 2006 Nov; 80(22):10957-71. PubMed ID: 16956950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
    Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation of dileucine-like motifs in the human immunodeficiency virus type 1 capsid disrupts virus assembly, gag-gag interactions, gag-membrane binding, and virion maturation.
    Joshi A; Nagashima K; Freed EO
    J Virol; 2006 Aug; 80(16):7939-51. PubMed ID: 16873251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 assembly and maturation.
    Bukrinskaya AG
    Arch Virol; 2004 Jun; 149(6):1067-82. PubMed ID: 15168195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gag protein from human immunodeficiency virus type 1 assembles in the absence of cyclophilin A.
    Streblow DN; Kitabwalla M; Pauza CD
    Virology; 1998 Dec; 252(1):228-34. PubMed ID: 9875332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.